2018 심방세동 카테터 절제술 대한민국 진료지침: Part I

키워드

참고문헌 (448)

1. Calkins H, "HRS", EHRA, Heart Rhythm, pp.2007, 4[DOI]
2. Camm AJ, "Guidelines for the management of atrial fibrillation : the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)", Europace, 12, pp.1360~1420 (2010)
3. January CT, "2014 AHA", ACC, American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol, 2014[DOI]
4. Lloyd-Jones DM, "Lifetime risk for development of atrial fibrillation : the Framingham Heart Study", Circulation, 110, pp.1042~1046 (2004)
5. Benjamin EJ, "Independent risk factors for atrial fibrillation in a populationbased cohort : The framingham heart study", JAMA, 271, pp.840~844 (1994)
6. Miller JD, "Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation", J Am Coll Cardiol, 66, pp.2899~2906 (2015)
7. Force ESCT, "European Heart Rhythm Association(EHRA)", European Association of Cardiovascular Prevention and Rehabilitation(EACPR)position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society(HRS)and Asia Pacific Heart Rhythm Society(APHRS), 2017, pp.19, 190~225
8. 이소령, "Prevalence of Nonnonevalvular Atrial Fibrillation Based on Geographical Distribution and Socioeconomic Status in the Entire Korean Population", Korean Circulation Journal, 48(7), pp.622~634 (2018), 대한심장학회[DOI]
9. Allan V, "Are cardiovascular risk factors also associated with the incidence of atrial fibrillation", Thromb Haemost, 117, pp.837~850 (2017)
10. de Vos CB, "Progression From Paroxysmal to Persistent Atrial Fibrillation : Clinical Correlates and Prognosis", J Am Coll Cardiol, 55, pp.725~731 (2010)
11. Wijffels MC, "Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats", Circulation, 92, pp.1954~1968 (1995)
12. Walters TE, "Progression of atrial remodeling in patients with high-burden atrial fibrillation : Implications for early ablative intervention", Heart Rhythm, 13, pp.331~339 (2016)
13. Heijman J, "Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression", Circ Res, 114, pp.1483~1499 (2014)
14. Wakili R, "Recent advances in the molecular pathophysiology of atrial fibrillation", J Clin Invest, 121, pp.2955~2968 (2011)
15. Kopecky SL, "The Natural History of Lone Atrial Fibrillation", N Engl J Med, 317, pp.669~674 (1987)
16. Kochhäuser S, "Predictors for Progression of Atrial Fibrillation in Patients Awaiting Atrial Fibrillation Ablation", Can J Cardiol, 32, pp.1348~1354 (2016)
17. Sugihara C, "The development of AF over time in patients with permanent pacemakers : objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF", EP Europace, 17, pp.864~870 (2015)
18. Arnar DO, "Familial aggregation of atrial fibrillation in Iceland", Eur Heart J, 27, pp.708~712 (2006)
19. Fox CS, "Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring", JAMA, 291, pp.2851~2855 (2004)
20. Lubitz SA, "Association between familial atrial fibrillation and risk of new-onset atrial fibrillation", JAMA, 304, pp.2263~2269 (2010)
21. Christophersen IE, "Genetics of atrial fibrillation : from families to genomes", J Hum Genet, 61, pp.61~ (2015)
22. Benjamin EJ, "Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry", Nature Genetics, 41, pp.879~ (2009)
23. Ellinor PT, "Meta-analysis identifies six new susceptibility loci for atrial fibrillation", Nature Genetics, 44, pp.670~ (2012)
24. Gudbjartsson DF, "Variants conferring risk of atrial fibrillation on chromosome 4q25", Nature, 448, pp.353~ (2007)
25. Gudbjartsson DF, "A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke", Nature Genetics, 41, pp.876~ (2009)
26. Sinner MF, "Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation", Circulation, 130, pp.1225~1235 (2014)
27. Lubitz SA, "Novel Genetic Markers Associate With Atrial Fibrillation Risk in Europeans and Japanese", J Am Coll Cardiol, 63, pp.1200~1210 (2014)
28. Tada H, "Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future atrial fibrillation and stroke", Stroke, 45, pp.2856~2862 (2014)
29. Everett BM, "Novel genetic markers improve measures of atrial fibrillation risk prediction", Eur Heart J, 34, pp.2243~2251 (2013)
30. Lubitz SA, "Genetic Risk Prediction of Atrial Fibrillation", Circulation, 135, pp.1311~1320 (2017)
31. Hucker WJ, "Atrial Fibrillation Genetics: Is There a Practical Clinical Value Now or in the Future", Can J Cardiol, 32, pp.1300~1305 (2016)
32. Kim SK, "Clinical and serological predictors for the recurrence of atrial fibrillation after electrical cardioversion", Europace, 11, pp.1632~1638 (2009)
33. Shoemaker MB, "Common genetic variants and response to atrial fibrillation ablation", Circ Arrhythm Electrophysiol, 8, pp.296~302 (2015)
34. Choi EK, "Korean Atrial Fibrillation (AF) Network: Genetic Variants for AF Do Not Predict Ablation Success", J Am Heart Assoc, 4, pp.e002046~ (2015)
35. Chugh SS, "Worldwide epidemiology of atrial fibrillation : a Global Burden of Disease 2010 Study", Circulation, 129, pp.837~847 (2014)
36. Colilla S, "Estimates of Current and Future Incidence and Prevalence of Atrial Fibrillation in the U.S. Adult Population", Am J Cardiol, 112, pp.1142~1147 (2013)
37. Kannel WB, "Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available", Am J Cardiol, 82, pp.2N~9N (1998)
38. Miller PS, "Are cost benefits of anticoagulation for stroke prevention in atrial fibrillation underestimated", Stroke, 36, pp.360~366 (2005)
39. Chen LY, "Atrial Fibrillation and Its Association With Sudden Cardiac Death", Circulation Journal, 78, pp.2588~2593 (2014)
40. Miyasaka Y, "Mortality Trends in Patients Diagnosed With First Atrial Fibrillation : A 21-Year Community-Based Study", J Am Coll Cardiol, 49, pp.986~992 (2007)
41. Lubitz SA, "Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community", J Am Heart Assoc, 2, pp.e000126~ (2013)
42. Wang TJ, "Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality : the Framingham Heart Study", Circulation, 107, pp.2920~2925 (2003)
43. Jacobs V, "Atrial fibrillation and dementia", Trends Cardiovasc Med, 25, pp.44~51 (2015)
44. Boriani G, "Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry", Am J Med, 128, pp.509~518.e2 (2015)
45. Go AS, "Executive summary : heart disease and stroke statistics--2014 update : a report from the American Heart Association", Circulation, 129, pp.399~410 (2014)
46. Kim MH, "Estimation of total incremental health care costs in patients with atrial fibrillation in the United States", Circ Cardiovasc Q ual Outcomes, 4, pp.313~320 (2011)
47. Ganesan AN, "The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding : a systematic review and meta-analysis", Eur Heart J, 37, pp.1591~1602 (2016)
48. Carlsson Jö, "Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation : The Strategies of Treatment of Atrial Fibrillation(STAF)study", J Am Coll Cardiol, 41, pp.1690~1696 (2003)
49. Roy D, "Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure", N Engl J Med, 358, pp.2667~2677 (2008)
50. Van Gelder IC, "A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation", N Engl J Med, 347, pp.1834~1840 (2002)
51. Wyse DG, "A comparison of rate control and rhythm control in patients with atrial fibrillation", N Engl J Med, 347, pp.1825~1833 (2002)
52. Hindricks G, "Perception of atrial fibrillation before and after radiofrequency catheter ablation : relevance of asymptomatic arrhythmia recurrence", Circulation, 112, pp.307~313 (2005)
53. Vasamreddy CR, "Symptomatic and Asymptomatic Atrial Fibrillation in Patients Undergoing Radiofrequency Catheter Ablation", J Cardiovasc Electrophysiol, 17, pp.134~139 (2006)
54. Verma A, "Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation(discern af) : A prospective, multicenter study", JAMA Internal Medicine, 173, pp.149~156 (2013)
55. Rienstra M, "Asymptomatic persistent atrial fibrillation and outcome : Results of the RACE study", Heart Rhythm, 11, pp.939~945 (2014)
56. Siontis KC, "Typical, atypical, and asymptomatic presentations of new-onset atrial fibrillation in the community : Characteristics and prognostic implications", Heart Rhythm, 13, pp.1418~1424 (2016)
57. Reynolds MR, "Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation : The Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle(FRACTAL)study", Am Heart J, 152, pp.1097~1103 (2006)
58. Pedrote A, "Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation : an observational study through a subcutaneous leadless cardiac monitor", J Cardiovasc Electrophysiol, 24, pp.1075~1082 (2013)
59. Wokhlu A, "Long-Term Q uality of Life After Ablation of Atrial Fibrillation : The Impact of Recurrence, Symptom Relief, and Placebo Effect", J Am Coll Cardiol, 55, pp.2308~2316 (2010)
60. Ho SY, "Anatomy of the left atrium : implications for radiofrequency ablation of atrial fibrillation", J Cardiovasc Electrophysiol, 10, pp.1525~1533 (1999)
61. Ho SY, "Left atrial anatomy revisited", Circ Arrhythm Electrophysiol, 5, pp.220~228 (2012)
62. Ho SY, "Anatomy of the left atrium for interventional electrophysiologists", Pacing Clin Electrophysiol, 33, pp.620~627 (2010)
63. Kato R, "Pulmonary vein anatomy in patients undergoing catheter ablation of atrial fibrillation : lessons learned by use of magnetic resonance imaging", Circulation, 107, pp.2004~2010 (2003)
64. Jongbloed MRM, "Noninvasive visualization of the cardiac venous system using multislice computed tomography", J Am Coll Cardiol, 45, pp.749~753 (2005)
65. Mlcochová H, "Magnetic Resonance Angiography of Pulmonary Veins : Implications for Catheter Ablation of Atrial Fibrillation", Pacing Clin Electrophysiol, 28, pp.1073~1080 (2005)
66. Nathan H, "The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts", Circulation, 34, pp.412~422 (1966)
67. Weiss C, "Impact of the distribution and structure of myocardium in the pulmonary veins for radiofrequency ablation of atrial fibrillation", Pacing Clin Electrophysiol, 25, pp.1352~1356 (2002)
68. Wang K, "Architecture of atrial musculature in humans", Br Heart J, 73, pp.559~565 (1995)
69. Pashakhanloo F, "Myofiber Architecture of the Human Atria as Revealed by Submillimeter Diffusion Tensor Imaging", Circ Arrhythm Electrophysiol, 9, pp.e004133~ (2016)
70. Haissaguerre M, "Intermittent drivers anchoring to structural heterogeneities as a major pathophysiological mechanism of human persistent atrial fibrillation", J Physiol, 594, pp.2387~2398 (2016)
71. Hansen BJ, "Atrial fibrillation driven by microanatomic intramural re-entry revealed by simultaneous subepicardial and sub-endocardial optical mapping in explanted human hearts", Eur Heart J, 36, pp.2390~2401 (2015)
72. Kim DT, "The ligament of Marshall : a structural analysis in human hearts with implications for atrial arrhythmias", J Am Coll Cardiol, 36, pp.1324~1327 (2000)
73. Cabrera JA, "The architecture of the left lateral atrial wall : a particular anatomic region with implications for ablation of atrial fibrillation", Eur Heart J, 29, pp.356~362 (2008)
74. Han S, "Electrophysiological characteristics of the Marshall bundle in humans", Heart Rhythm, 7, pp.786~793 (2010)
75. Gittenberger-de Groot AC, "The role of neural crest and epicardium-derived cells in conduction system formation", Novartis Found Symp, 250, pp.125~134 (2003)
76. Jongbloed MR, "Embryonic Conduction Tissue", J Cardiovasc Electrophysiol, 15, pp.349~355 (2004)
77. Perez-Lugones A, "Evidence of Specialized Conduction Cells in Human Pulmonary Veins of Patients with Atrial Fibrillation", J Cardiovasc Electrophysiol, 14, pp.803~809 (2003)
78. Chen YC, "Heterogeneous Expression of Potassium Currents and Pacemaker Currents Potentially Regulates Arrhythmogenesis of Pulmonary Vein Cardiomyocytes", J Cardiovasc Electrophysiol, 20, pp.1039~1045 (2009)
79. Ehrlich JR, "Cellular electrophysiology of canine pulmonary vein cardiomyocytes : action potential and ionic current properties", J Physiol, 551, pp.801~813 (2003)
80. Verheule S, "Tissue structure and connexin expression of canine pulmonary veins", Cardiovasc Res, 55, pp.727~738 (2002)
81. Honjo H, "Pacing-induced spontaneous activity in myocardial sleeves of pulmonary veins after treatment with ryanodine", Circulation, 107, pp.1937~1943 (2003)
82. Levin MD, "Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers", J Clin Invest, 119, pp.3420~3436 (2009)
83. Wongcharoen W, "Effects of a Na+", Ca2+ exchanger inhibitor on pulmonary vein electrical activity and ouabain-induced arrhythmogenicity, 2006, pp.70, 497~508
84. Weerasooriya R, "Dissociated Pulmonary Vein Arrhythmia", J Cardiovasc Electrophysiol, 14, pp.1173~1179 (2003)
85. Hocini M, "Electrical conduction in canine pulmonary veins : electrophysiological and anatomic correlation", Circulation, 105, pp.2442~2448 (2002)
86. Arora R, "Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping", Circulation, 107, pp.1816~1821 (2003)
87. Özgen N, "Early electrical remodeling in rabbit pulmonary vein results from trafficking of intracellular SK2channels to membrane sites", Cardiovasc Res, 75, pp.758~769 (2007)
88. Kalifa J, "Intra-atrial pressure increases rate and organization of waves emanating from the superior pulmonary veins during atrial fibrillation", Circulation, 108, pp.668~671 (2003)
89. Chen SA, "Catheter Ablation of Atrial Fibrillation Originating from the Non-Pulmonary Vein Foci", J Cardiovasc Electrophysiol, 16, pp.229~232 (2005)
90. Jais P, "Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation", Circulation, 106, pp.2479~2485 (2002)
91. Kumagai K, "Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter", J Am Coll Cardiol, 43, pp.2281~2289 (2004)
92. Atienza F, "Activation of inward rectifier potassium channels accelerates atrial fibrillation in humans : evidence for a reentrant mechanism", Circulation, 114, pp.2434~2442 (2006)
93. Sanders P, "Spectral analysis identifies sites of high-frequency activity maintaining atrial fibrillation in humans", Circulation, 112, pp.789~797 (2005)
94. Hou Y, "Neuromodulation for cardiac arrhythmia", Heart Rhythm, 13, pp.584~592 (2016)
95. Chiou CW, "Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes", Circulation, 95, pp.2573~2584 (1997)
96. Kawashima T, "The autonomic nervous system of the human heart with special reference to its origin, course, and peripheral distribution", Anat Embryol(Berl), 209, pp.425~438 (2005)
97. Armour JA, "Gross and microscopic anatomy of the human intrinsic cardiac nervous system", The Anatomical Record, 247, pp.289~298 (1997)
98. Pauza DH, "Morphology of the Intrinsic Cardiac Nervous System in the Dog : A Whole-Mount Study Employing Histochemical Staining with Acetylcholinesterase", Cells Tissues Organs, 172, pp.297~320 (2002)
99. Po SS, "Localization of Left Atrial Ganglionated Plexi in Patients with Atrial Fibrillation", J Cardiovasc Electrophysiol, 20, pp.1186~1189 (2009)
100. Hou Y, "Ganglionated Plexi Modulate Extrinsic Cardiac Autonomic Nerve Input : Effects on Sinus Rate, Atrioventricular Conduction, Refractoriness, and Inducibility of Atrial Fibrillation", J Am Coll Cardiol, 50, pp.61~68 (2007)
101. Chevalier P, "Quantitative study of nerves of the human left atrium", Heart Rhythm, 2, pp.518~522 (2005)
102. Tan AY, "Autonomic Innervation and Segmental Muscular Disconnections at the Human Pulmonary Vein-Atrial Junction : Implications for Catheter Ablation of Atrial-Pulmonary Vein Junction", J Am Coll Cardiol, 48, pp.132~143 (2006)
103. Chen PS, "Role of the autonomic nervous system in atrial fibrillation : pathophysiology and therapy", Circ Res, 114, pp.1500~1515 (2014)
104. Po SS, "Experimental model for paroxysmal atrial fibrillation arising at the pulmonary vein-atrial junctions", Heart Rhythm, 3, pp.201~208 (2006)
105. Scherlag BJ, "Autonomically Induced Conversion of Pulmonary Vein Focal Firing Into Atrial Fibrillation", J Am Coll Cardiol, 45, pp.1878~1886 (2005)
106. Jayachandran JV, "Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation", Circulation, 101, pp.1185~1191 (2000)
107. Lu Z, "Atrial fibrillation begets atrial fibrillation : autonomic mechanism for atrial electrical remodeling induced by short-term rapid atrial pacing", Circ Arrhythm Electrophysiol, 1, pp.184~192 (2008)
108. Patterson E, "Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation", Heart Rhythm, 2, pp.624~631 (2005)
109. Zhou J, "Gradients of Atrial Refractoriness and Inducibility of Atrial Fibrillation due to Stimulation of Ganglionated Plexi", J Cardiovasc Electrophysiol, 18, pp.83~90 (2007)
110. Choi EK, "Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs", Circulation, 121, pp.2615~2623 (2010)
111. Choi EK, "Ganglionated plexi as neuromodulation targets for atrial fibrillation", J Cardiovasc Electrophysiol, 28, pp.1485~1491 (2017)
112. Katritsis D, "Anatomic Approach for Ganglionic Plexi Ablation in Patients With Paroxysmal Atrial Fibrillation", Am J Cardiol, 102, pp.330~334 (2008)
113. Lemery R, "Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation", Heart Rhythm, 3, pp.387~396 (2006)
114. Pokushalov E, "Selective ganglionated plexi ablation for paroxysmal atrial fibrillation", Heart Rhythm, 6, pp.1257~1264 (2009)
115. Scanavacca M, "Selective atrial vagal denervation guided by evoked vagal reflex to treat patients with paroxysmal atrial fibrillation", Circulation, 114, pp.876~885 (2006)
116. Katritsis DG, "Rapid pulmonary vein isolation combined with autonomic ganglia modification : A randomized study", Heart Rhythm, 8, pp.672~678 (2011)
117. Katritsis DG, "Autonomic Denervation Added to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation : A Randomized Clinical Trial", J Am Coll Cardiol, 62, pp.2318~2325 (2013)
118. Driessen AHG, "Ganglion Plexus Ablation in Advanced Atrial Fibrillation : The AFACT Study", J Am Coll Cardiol, 68, pp.1155~1165 (2016)
119. Nakagawa H, "Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation", Heart Rhythm, 6, pp.S26~S34 (2009)
120. Chen J, "Back to the Future : The Role of the Autonomic Nervous System in Atrial Fibrillation", Pacing Clin Electrophysiol, 29, pp.413~421 (2006)
121. Bauer A, "Effects of circumferential or segmental pulmonary vein ablation for paroxysmal atrial fibrillation on cardiac autonomic function", Heart Rhythm, 3, pp.1428~1435 (2006)
122. Pokushalov E, "A Randomized Comparison of Pulmonary Vein Isolation With Versus Without Concomitant Renal Artery Denervation in Patients With Refractory Symptomatic Atrial Fibrillation and Resistant Hypertension", J Am Coll Cardiol, 60, pp.1163~1170 (2012)
123. Tsai W-C, "Effects of renal sympathetic denervation on the stellate ganglion and brain stem in dogs", Heart Rhythm, 14, pp.255~262 (2017)
124. Chrispin J, "Clinical predictors of cardiac magnetic resonance late gadolinium enhancement in patients with atrial fibrillation", Europace, 19, pp.371~377 (2017)
125. Cochet H, "Age, Atrial Fibrillation, and Structural Heart Disease Are the Main Determinants of Left Atrial Fibrosis Detected by Delayed-Enhanced Magnetic Resonance Imaging in a General Cardiology Population", J Cardiovasc Electrophysiol, 26, pp.484~492 (2015)
126. Kottkamp H, "Fibrotic Atrial Cardiomyopathy : A Specific Disease", Syndrome Supplying Substrates for Atrial Fibrillation, Atrial Tachycardia, Sinus Node Disease, AV Node Disease, and Thromboembolic Complications, 2012, pp.23, 797~799
127. Kottkamp H, "Human atrial fibrillation substrate : towards a specific fibrotic atrial cardiomyopathy", Eur Heart J, 34, pp.2731~2738 (2013)
128. Mahnkopf C, "Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI : Implications for disease progression and response to catheter ablation", Heart Rhythm, 7, pp.1475~1481 (2010)
129. Konrad T, "Primary Persistent Atrial Fibrillation : A Distinct Arrhythmia Subentity of an Ablation Population", J Cardiovasc Electrophysiol, 26, pp.1289~1294 (2015)
130. Anné W, "Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation", Cardiovasc Res, 67, pp.655~666 (2005)
131. de Oliveira ÍM, "Fibrosis, myocardial crossings, disconnections, abrupt turns, and epicardial reflections : do they play an actual role in human permanent atrial fibrillation? A controlled necropsy study", Cardiovascular Pathology, 22, pp.65~69 (2013)
132. Smorodinova N, "Bioptic Study of Left and Right Atrial Interstitium in Cardiac Patients with and without Atrial Fibrillation: Interatrial but Not Rhythm-Based Differences", PLOS ONE, 10, pp.e0129124~ (2015)
133. Platonov PG, "Structural Abnormalities in Atrial Walls Are Associated With Presence and Persistency of Atrial Fibrillation But Not With Age", J Am Coll Cardiol, 58, pp.2225~2232 (2011)
134. Kottkamp H, "Box Isolation of Fibrotic Areas(BIFA) : A Patient-Tailored Substrate Modification Approach for Ablation of Atrial Fibrillation", J Cardiovasc Electrophysiol, 27, pp.22~30 (2015)
135. Andrade J, "The clinical profile and pathophysiology of atrial fibrillation : relationships among clinical features, epidemiolog y, and mechanisms", Circ Res, 114, pp.1453~1468 (2014)
136. Andrade J, "The time course of exit and entrance block during cryoballoon pulmonary vein isolation", EP Europace, 16, pp.500~504 (2014)
137. Andrade JG, "Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation : insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation(STOP AF)Trial", Circ Arrhythm Electrophysiol, 7, pp.69~75 (2014)
138. Akoum N, "Atrial Fibrosis Quantified Using Late Gadolinium Enhancement MRI is Associated With Sinus Node Dysfunction Requiring Pacemaker Implant", J Cardiovasc Electrophysiol, 23, pp.44~50 (2011)
139. Kottkamp H, "The Substrate in"Early Persistent"Atrial Fibrillation : Arrhythmia Induced, Risk Factor Induced, or From a Specific Fibrotic Atrial Cardiomyopathy?", JACC : Clinical Electrophysiology, 2, pp.140~142 (2016)
140. Jalife J, "Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both", J Cardiovasc Electrophysiol, 9, pp.S2~S12 (1998)
141. Goette A, "EHRA", HRS, SOLAECE expert consensus on atrial cardiomyopathies : definition, characterization, and clinical implication, pp.EP Europace, 2016[DOI]
142. Nattel S, "Mechanisms of Atrial Fibrillation : Lessons From Animal Models", Prog Cardiovasc Dis, 48, pp.9~28 (2005)
143. Potpara TS, "A 12-Year Follow-up Study of Patients With Newly Diagnosed Lone Atrial Fibrillation : Implications of Arrhythmia Progression on Prognosis : The Belgrade Atrial Fibrillation Study", Chest, 141, pp.339~347 (2012)
144. Holmqvist F, "Heart rate is associated with progression of atrial fibrillation, independent of rhythm", Heart, 101, pp.894~899 (2015)
145. Veasey RA, "The natural history of atrial fibrillation in patients with permanent pacemakers: is atrial fibrillation a progressive disease", J Interv Card Electrophysiol, 44, pp.23~30 (2015)
146. Allessie M, "Electrical, contractile and structural remodeling during atrial fibrillation", Cardiovasc Res, 54, pp.230~246 (2002)
147. Filgueiras-Rama D, "Long-term frequency gradients during persistent atrial fibrillation in sheep are associated with stable sources in the left atrium", Circ Arrhythm Electrophysiol, 5, pp.1160~1167 (2012)
148. Nattel S, "Atrial remodeling and atrial fibrillation : mechanisms and implications", Circ Arrhythm Electrophysiol, 1, pp.62~73 (2008)
149. Pandit SV, "Rotors and the dynamics of cardiac fibrillation", Circ Res, 112, pp.849~862 (2013)
150. Martins RP, "Dominant frequency increase rate predicts transition from paroxysmal to long-term persistent atrial fibrillation", Circulation, 129, pp.1472~1482 (2014)
151. Nattel S, "Paroxysmal Atrial Fibrillation and Pulmonary Veins : Relationships Between Clinical Forms and Automatic Versus Re-entrant Mechanisms", Can J Cardiol, 29, pp.1147~1149 (2013)
152. Pinho-Gomes AC, "Targeting Inflammation and Oxidative Stress in Atrial Fibrillation : Role of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibition with Statins", Antioxid Redox Signal, 20, pp.1268~1285 (2014)
153. Corradi D, "Atrial fibrillation from the pathologist’s perspective", Cardiovasc Pathol, 23, pp.71~84 (2014)
154. Nattel S, "The multidimensional role of calcium in atrial fibrillation pathophysiology : mechanistic insights and therapeutic opportunities", Eur Heart J, 33, pp.1870~1877 (2012)
155. Wei SK, "Muscarinic modulation of the sodium-calcium exchanger in heart failure", Circulation, 115, pp.1225~1233 (2007)
156. He X, "Atrial fibrillation induces myocardial fibrosis through angiotensin II type 1 receptor-specific Arkadia-mediated downregulation of Smad7", Circ Res, 108, pp.164~175 (2011)
157. Schiller M, "TGF-β-induced SMAD signaling and gene regulation : consequences for extracellular matrix remodeling and wound healing", J Dermatol Sci, 35, pp.83~92 (2004)
158. Ben Amar M, "Towards a unified approach in the modeling of fibrosis : A review with research perspectives", Physics of Life Reviews, 17, pp.61~85 (2016)
159. Jalife J, "Mechanisms of persistent atrial fibrillation", Curr Opin Cardiol, 29, pp.20~27 (2014)
160. Jalife J, "Atrial remodeling, fibrosis, and atrial fibrillation", Trends Cardiovasc Med, 25, pp.475~484 (2015)
161. de Bakker JM, "Slow conduction in the infarcted human heart. 'Zigzag' course of activation", Circulation, 88, pp.915~926 (1993)
162. Bian W, "Structure-related initiation of reentry by rapid pacing in monolayers of cardiac cells", Circ Res, 98, pp.e29~e38 (2006)
163. Spach MS, "Microfibrosis produces electrical load variations due to loss of side-to-side cell connections : a major mechanism of structural heart disease arrhythmias", Pacing Clin Electrophysiol, 20, pp.397~413 (1997)
164. de Bakker JMT, "Three-dimensional anatomic structure as substrate for ventricular tachycardia", ventricular fibrillation, 2005, pp.2, 777~779
165. Valderrábano M, "Obstacle-induced transition from ventricular fibrillation to tachycardia in isolated swine right ventricles : Insights into the transition dynamics and implications for the critical mass", J Am Coll Cardiol, 36, pp.2000~2008 (2000)
166. Choi JI, "Changes in left atrial structure and function after catheter ablation and electrical cardioversion for atrial fibrillation", Circ J, 72, pp.2051~2057 (2008)
167. Basso C, "Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy", Just a matter of fat? Cardiovascular Pathology, 14, pp.37~41 (2005)
168. Roberts-Thomson KC, "Sinus Node Disease : An Idiopathic Right Atrial Myopathy", Trends Cardiovasc Med, 17, pp.211~214 (2007)
169. Haemers P, "Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria", Eur Heart J, 38, pp.53~61 (2017)
170. Pathak RK, "The Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management", Can J Cardiol, 31, pp.203~210 (2015)
171. Nalliah CJ, "The role of obesity in atrial fibrillation", Eur Heart J, 37, pp.1565~1572 (2016)
172. Mahajan R, "Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity", J Am Coll Cardiol, 66, pp.1~11 (2015)
173. Goette A, "Atrial amyloidosis and atrial fibrillation: a gender-dependent “arrhythmogenic substrate”?", Eur Heart J, 25, pp.1185~1186 (2004)
174. Podduturi V, "Isolated Atrial Amyloidosis and the Importance of Molecular Classification", Proc(Bayl Univ Med Cent), 26, pp.387~389 (2013)
175. Rocken C, "Atrial amyloidosis : an arrhythmogenic substrate for persistent atrial fibrillation", Circulation, 106, pp.2091~2097 (2002)
176. Hove-Madsen L, "Atrial fibrillation is associated with increased spontaneous calcium release from the sarcoplasmic reticulum in human atrial myocytes", Circulation, 110, pp.1358~1363 (2004)
177. Wang L, "Optical mapping of sarcoplasmic reticulum Ca2+in the intact heart : ryanodine receptor refractoriness during alternans and fibrillation", Circ Res, 114, pp.1410~1421 (2014)
178. Greiser M, "Dynamic remodeling of intracellular Ca2+ signaling during atrial fibrillation", J Mol Cell Cardiol, 58, pp.134~142 (2013)
179. Voigt N, "Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation", Circulation, 125, pp.2059~2070 (2012)
180. Chiang DY, "Loss of microRNA-106b-25 cluster promotes atrial fibrillation by enhancing ryanodine receptor type-2 expression and calcium release", Circ Arrhythm Electrophysiol, 7, pp.1214~1222 (2014)
181. Li N, "Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model", Circulation, 129, pp.1276~1285 (2014)
182. Dong LW, "Impairment of the ryanodinesensitive calcium release channels in the cardiac sarcoplasmic reticulum and its underlying mechanism during the hypodynamic phase of sepsis", Shock, 16, pp.33~39 (2001)
183. Caballero R, "In Humans, Chronic Atrial Fibrillation Decreases the Transient Outward Current and Ultrarapid Component of the Delayed Rectifier Current Differentially on Each Atria and Increases the Slow Component of the Delayed Rectifier Current in Both", J Am Coll Cardiol, 55, pp.2346~2354 (2010)
184. Van Wagoner DR, "Atrial L-type Ca2+ currents and human atrial fibrillation", Circ Res, 85, pp.428~436 (1999)
185. Voigt N, "Left-to-right atrial inward rectifier potassium current gradients in patients with paroxysmal versus chronic atrial fibrillation", Circ Arrhythm Electrophysiol, 3, pp.472~480 (2010)
186. Deshmukh A, "Left atrial transcriptional changes associated with atrial fibrillation susceptibility and persistence", Circ Arrhythm Electrophysiol, 8, pp.32~41 (2015)
187. Nattel S, "Changes in the atrial transcriptome and atrial fibrillation : susceptibility, persistence, causes, and consequences", Circ Arrhythm Electrophysiol, 8, pp.5~7 (2015)
188. Jalife J, "Mother rotors and fibrillatory conduction : a mechanism of atrial fibrillation", Cardiovasc Res, 54, pp.204~216 (2002)
189. Nattel S, "New ideas about atrial fibrillation 50 years on", Nature, 415, pp.219~ (2002)
190. Schotten U, "Pathophysiological Mechanisms of Atrial Fibrillation : A Translational Appraisal", Physiological Reviews, 91, pp.265~325 (2011)
191. Haïssaguerre M, "Spontaneous Initiation of Atrial Fibrillation by Ectopic Beats Originating in the Pulmonary Veins", N Engl J Med, 339, pp.659~666 (1998)
192. Moe GK, "A computer model of atrial fibrillation", Am Heart J, 67, pp.200~220 (1964)
193. Garrey WE, "The Nature of Fibrillary Contraction of the Heart.-Its Relation to Tissue Mass and Form", American Journal of Physiology-Legacy Content, 33, pp.397~414 (1914)
194. Jalife J, "Déjà vu in the theories of atrial fibrillation dynamics", Cardiovasc Res, 89, pp.766~775 (2011)
195. Lewis T, "Oliver-Sharpey Lectures on the Nature of Flutter and Fibrillation of the Auricle", British Medical Journal, 1, pp.551~555 (1921)
196. Boer RA, "Galectin-3 : a novel mediator of heart failure development and progression", Eur J Heart Fail, 11, pp.811~817 (2009)
197. Chen YJ, "Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins : implication in initiation of atrial fibrillation", Circulation, 104, pp.2849~2854 (2001)
198. Voigt N, "Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation", Circulation, 129, pp.145~156 (2014)
199. Christ T, "Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation", Proceedings of the National Academy of Sciences, 111, pp.11193~11198 (2014)
200. Greiser M, "Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes", J Clin Invest, 124, pp.4759~4772 (2014)
201. Lee S-H, "Predictors of Non-Pulmonary Vein Ectopic Beats Initiating Paroxysmal Atrial Fibrillation : Implication for Catheter Ablation", J Am Coll Cardiol, 46, pp.1054~1059 (2005)
202. Allessie MA, "Circus movement in rabbit atrial muscle as a mechanism of trachycardia", Circ Res, 33, pp.54~62 (1973)
203. Mines GR, "On circulating excitations in heart muscle and their possible relation to tachycardia and fibrillation", Trans R Soc Can, 8, pp.43~52 (1914)
204. Wiener N, "The mathematical formulation of the problem of conduction of impulses in a network of connected excitable elements, specifically in cardiac muscle", Arch Inst Cardiol Mex, 16, pp.205~265 (1946)
205. Allessie MA, "Circus movement in rabbit atrial muscle as a mechanism of tachycardia. III. The "leading circle" concept: a new model of circus movement in cardiac tissue without the involvement of an anatomical obstacle", Circ Res, 41, pp.9~18 (1977)
206. Winfree AT, "Varieties of spiral wave behavior : An experimentalist’s approach to the theory of excitable media", Chaos : An Interdisciplinary Journal of Nonlinear Science, 1, pp.303~334 (1991)
207. Rensma PL, "Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs", Circ Res, 62, pp.395~410 (1988)
208. Winfree AT, "Vortex Action Potentials in Normal Ventricular Musclea", Ann N Y Acad Sci, 591, pp.190~207 (1990)
209. Davidenko JM, "Sustained vortex-like waves in normal isolated ventricular muscle", Proc Natl Acad Sci U S A, 87, pp.8785~8789 (1990)
210. Fast VG, "Role of wavefront curvature in propagation of cardiac impulse", Cardiovasc Res, 33, pp.258~271 (1997)
211. Zhao J, "Integration of High-Resolution Optical Mapping and 3-Dimensional Micro-Computed Tomographic Imaging to Resolve the Structural Basis of Atrial Conduction in the Human Heart", Circ Arrhythm Electrophysiol, 8, pp.1514~1517 (2015)
212. Kneller J, "Mechanisms of atrial fibrillation termination by pure sodium channel blockade in an ionically-realistic mathematical model", Circ Res, 96, pp.e35~e47 (2005)
213. Cuculich PS, "Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns", Circulation, 122, pp.1364~1372 (2010)
214. Haissaguerre M, "Driver domains in persistent atrial fibrillation", Circulation, 130, pp.530~538 (2014)
215. Narayan SM, "Ablation of Rotor and Focal Sources Reduces Late Recurrence of Atrial Fibrillation Compared With Trigger Ablation Alone : Extended Follow-Up of the CONFIRM Trial(Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation)", J Am Coll Cardiol, 63, pp.1761~1768 (2014)
216. Lin YJ, "Prevalence, characteristics, mapping, and catheter ablation of potential rotors in nonparoxysmal atrial fibrillation", Circ Arrhythm Electrophysiol, 6, pp.851~358 (2013)
217. Lin Y-J, "Benefits of Atrial Substrate Modification Guided by Electrogram Similarity and Phase Mapping Techniques to Eliminate Rotors and Focal Sources Versus Conventional Defragmentation in Persistent Atrial Fibrillation", JACC : Clinical Electrophysiology, 2, pp.667~678 (2016)
218. Lee S, "Simultaneous Biatrial High-Density(510-512Electrodes)Epicardial Mapping of Persistent and Long-Standing Persistent Atrial Fibrillation in Patients : New Insights Into the Mechanism of Its Maintenance", Circulation, 132, pp.2108~2117 (2015)
219. van der Does LJME, "Dynamics of Endo- and Epicardial Focal Fibrillation Waves at the Right Atrium in a Patient With Advanced Atrial Remodelling", Can J Cardiol, 32, pp.1260.e19~1260.e21 (2016)
220. de Groot N, "Direct Proof of Endo-Epicardial Asynchrony of the Atrial Wall During Atrial Fibrillation in Humans", Circ Arrhythm Electrophysiol, 9 (2016)
221. Perez FJ, "Long-term outcomes after catheter ablation of cavotricuspid isthmus dependent atrial flutter : a meta-analysis", Circ Arrhythm Electrophysiol, 2, pp.393~401 (2009)
222. Hsu LF, "Atrial fibrillation originating from persistent left superior vena cava", Circulation, 109, pp.828~832 (2004)
223. Pappone C, "Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation : Outcomes from a controlled nonrandomized long-term study", J Am Coll Cardiol, 42, pp.185~197 (2003)
224. Chen MS, "Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function", J Am Coll Cardiol, 43, pp.1004~1009 (2004)
225. Gentlesk PJ, "Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation", J Cardiovasc Electrophysiol, 18, pp.9~14 (2007)
226. Khan MN, "Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure", N Engl J Med, 359, pp.1778~1785 (2008)
227. MacDonald MR, "Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction : a randomised controlled trial", Heart, 97, pp.740~747 (2011)
228. Marrouche NF, "Catheter Ablation for Atrial Fibrillation with Heart Failure", N Engl J Med, 378, pp.417~427 (2018)
229. Hunter RJ, "A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure(the CAMTAF trial)", Circ Arrhythm Electrophysiol, 7, pp.31~38 (2014)
230. Themistoclakis S, "The Risk of Thromboembolism and Need for Oral Anticoagulation After Successful Atrial Fibrillation Ablation", J Am Coll Cardiol, 55, pp.735~743 (2010)
231. Bunch TJ, "Patients Treated with Catheter Ablation for Atrial Fibrillation Have Long-Term Rates of Death, Stroke, and Dementia Similar to Patients Without Atrial Fibrillation", J Cardiovasc Electrophysiol, 22, pp.839~845 (2011)
232. Dagres N, "A Systematic Review and Meta-Analysis", J Card Fail, 17, pp.964~970 (2011)
233. Lin Y-J, "Successful catheter ablation reduces the risk of cardiovascular events in atrial fibrillation patients with CHA2DS2-VASc risk score of 1 and higher", EP Europace, 15, pp.676~684 (2013)
234. Ghanbari H, "Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation", Heart Rhythm, 11, pp.1503~1511 (2014)
235. Gaita F, "Very Long-Term Results of Surgical and Transcatheter Ablation of Long-Standing Persistent Atrial Fibrillation", The Annals of Thoracic Surgery, 96, pp.1273~1278 (2013)
236. Ganesan AN, "Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis", J Am Heart Assoc, 2, pp.e004549~ (2013)
237. Gi-Hyeon Seo, "Efficacy and Safety Outcomes of Catheter Ablation of Non-valvular Atrial Fibrillation in Korean Practice: Analysis of Nationwide Claims Data", International Journal of Arrhythmia, 19(1), pp.14~21 (2018), 대한부정맥학회[DOI]
238. Oral H, "Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation", J Am Coll Cardiol, 40, pp.100~104 (2002)
239. Joshi S, "Prevalence, Predictors, and Prognosis of Atrial Fibrillation Early After Pulmonary Vein Isolation : Findings from 3 Months of Continuous Automatic ECG Loop Recordings", J Cardiovasc Electrophysiol, 20, pp.1089~1094 (2009)
240. Andrade JG, "Incidence and Significance of Early Recurrences Associated with Different Ablation Strategies for AF : A STAR-AF Substudy", J Cardiovasc Electrophysiol, 23, pp.1295~1301 (2012)
241. Grubman E, "Histopathologic Effects of Radiofrequency Catheter Ablation in Previously Infarcted Human Myocardium", J Cardiovasc Electrophysiol, 10, pp.336~342 (1999)
242. Hsieh MH, "Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins", Circulation, 100, pp.2237~2243 (1999)
243. Fenelon G, "Delayed Effects of Radiofrequency Energy : Mechanisms and Clinical Implications", Pacing Clin Electrophysiol, 19, pp.484~489 (1996)
244. Opolski PLAMKAEKAAPAPBAJKAPSARPAG, "Does a blanking period after pulmonary vein isolation impact long-term results? Results after 55 months of follow-up" (2014)
245. Liang JJ, "Early recurrence of atrial arrhythmias following pulmonary vein antral isolation: Timing and frequency of early recurrences predicts long-term ablation success", Heart Rhythm, 12, pp.2461~2468 (2015)
246. Jais P, "Catheter ablation versus antiarrhythmic drugs for atrial fibrillation : the A4 study", Circulation, 118, pp.2498~2505 (2008)
247. Calkins H, "Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation : two systematic literature reviews and meta-analyses", Circ Arrhythm Electrophysiol, 2, pp.349~361 (2009)
248. Verma A, "Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction", Circulation, 112, pp.627~635 (2005)
249. Eitel C, "Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block : The paceand-ablate approach", Heart Rhythm, 7, pp.157~164 (2010)
250. Macle L, "Adenosineguided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation : an international, multicentre, randomised superiority trial", The Lancet, 386, pp.672~679 (2015)
251. Ouyang F, "Long-term results of catheter ablation in paroxysmal atrial fibrillation : lessons from a 5-year follow-up", Circulation, 122, pp.2368~2377 (2010)
252. Weerasooriya R, "Catheter Ablation for Atrial Fibrillation: Are Results Maintained at 5 Years of Follow-Up", J Am Coll Cardiol, 57, pp.160~166 (2011)
253. Wokhlu A, "Long-Term Outcome of Atrial Fibrillation Ablation : Impact and Predictors of Very Late Recurrence", J Cardiovasc Electrophysiol, 21, pp.1071~1078 (2010)
254. Hsieh MH, "The Different Mechanisms Between Late and Very Late Recurrences of Atrial Fibrillation in Patients Undergoing a Repeated Catheter Ablation", J Cardiovasc Electrophysiol, 17, pp.231~235 (2006)
255. Sotomi Y, "Cause of Very Late Recurrence of Atrial Fibrillation or Flutter After Catheter Ablation for Atrial Fibrillation", Am J Cardiol, 111, pp.552~556 (2013)
256. Mainigi SK, "Incidence and Predictors of Very Late Recurrence of Atrial Fibrillation After Ablation", J Cardiovasc Electrophysiol, 18, pp.69~74 (2007)
257. Park HC, "Left atrial functional reservoir : predictive value for outcome of catheter ablation in paroxysmal atrial fibrillation", Int J Cardiovasc Imaging, 30, pp.1423~1434 (2014)
258. Gaztañaga L, "Time to recurrence of atrial fibrillation influences outcome following catheter ablation", Heart Rhythm, 10, pp.2~9 (2013)
259. Camm AJ, "Guidelines for the management of atrial fibrillation : the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC)", Europace, 12, pp.1360~1420 (2010)
260. Miller JD, "Obesity, Exercise, Obstructive Sleep Apnea, and Modifiable Atherosclerotic Cardiovascular Disease Risk Factors in Atrial Fibrillation", J Am Coll Cardiol, 66, pp.2899~2906 (2015)
261. January CT, "2014 AHA", ACC, American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society, pp.J Am Coll Cardiol, 2014[DOI]
262. Lloyd-Jones DM, "Lifetime risk for development of atrial fibrillation : the Framingham Heart Study", Circulation, 110, pp.1042~1046 (2004)
263. Dublin S, "Risk of new-onset atrial fibrillation in relation to body mass index", Arch Intern Med, 166, pp.2322~2328 (2006)
264. Gami AS, "Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation", J Am Coll Cardiol, 49, pp.565~571 (2007)
265. Tedrow UB, "The long-and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS(women's health study)", J Am Coll Cardiol, 55, pp.2319~2327 (2010)
266. Huxley RR, "Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors : the Atherosclerosis Risk in Communities(ARIC)study", Circulation, 123, pp.1501~1508 (2011)
267. Mahajan R, "Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity", J Am Coll Cardiol, 66, pp.1~11 (2015)
268. Munger TM, "Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation", J Am Coll Cardiol, 60, pp.851~860 (2012)
269. Abed HS, "Obesity results in progressive atrial structural and electrical remodeling : implications for atrial fibrillation", Heart Rhythm, 10, pp.90~100 (2013)
270. Wokhlu A, "Long-term outcome of atrial fibrillation ablation : impact and predictors of very late recurrence", J Cardiovasc Electrophysiol, 21, pp.1071~1078 (2010)
271. Richter B, "Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor", Eur Heart J, 27, pp.2553~2559 (2006)
272. Jongnarangsin K, "Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation", J Cardiovasc Electrophysiol, 19, pp.668~672 (2008)
273. Shah AN, "Long-term outcome following successful pulmonary vein isolation : pattern and prediction of very late recurrence", J Cardiovasc Electrophysiol, 19, pp.661~667 (2008)
274. Letsas KP, "Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation : the potential role of inflammation", Europace, 11, pp.158~163 (2009)
275. Tang RB, "Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation", Circ J, 73, pp.438~443 (2009)
276. Jin Hwang H, "Atrial electroanatomical remodeling as a determinant of different outcomes between two current ablation strategies: circumferential pulmonary vein isolation vs pulmonary vein isolation", Clin Cardiol, 33, pp.E69~E74 (2010)
277. Patel D, "Outcomes and complications of catheter ablation for atrial fibrillation in females", Heart Rhythm, 7, pp.167~172 (2010)
278. Patel D, "Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea : the impact of continuous positive airway pressure", Circ Arrhythm Electrophysiol, 3, pp.445~451 (2010)
279. Patel D, "The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females", Europace, 12, pp.322~330 (2010)
280. Chao TF, "Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation", Circ J, 75, pp.2326~2332 (2011)
281. Winkle RA, "Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes", Am J Cardiol, 108, pp.374~379 (2011)
282. Wong CX, "Pericardial fat is associated with atrial fibrillation severity and ablation outcome", J Am Coll Cardiol, 57, pp.1745~1751 (2011)
283. Kang JH, "Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion", J Cardiovasc Electrophysiol, 23, pp.1165~1170 (2012)
284. Mohanty S, "Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation", J Am Coll Cardiol, 59, pp.1295~1301 (2012)
285. Ejima K, "Impact of diastolic dysfunction on the outcome of catheter ablation in patients with atrial fibrillation", Int J Cardiol, 164, pp.88~93 (2013)
286. Letsas KP, "The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation", Int J Cardiol, 164, pp.94~98 (2013)
287. Wong CX, "Obesity and the Risk of Incident, Post-Operative, and Post-Ablation Atrial Fibrillation : A Meta-Analysis of 626, 603 Individuals in 51 Studies", JACC Clin Electrophysiol, 1, pp.139~152 (2015)
288. Alonso A, "Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial", Am Heart J, 170, pp.770~777.e5 (2015)
289. Pathak RK, "Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation : the ARREST-AF cohort study", J Am Coll Cardiol, 64, pp.2222~2231 (2014)
290. Bitter T, "Sleep-Disordered Breathing and Cardiac Arrhythmias", Can J Cardiol, 31, pp.928~934 (2015)
291. Fletcher EC, "Effect of episodic hypoxia on sympathetic activity and blood pressure", Respir Physiol, 119, pp.189~197 (2000)
292. Kraiczi H, "Increased vasoconstrictor sensitivity in obstructive sleep apnea", J Appl Physiol(1985), 89, pp.493~498 (2000)
293. Ghias M, "The role of ganglionated plexi in apnea-related atrial fibrillation", J Am Coll Cardiol, 54, pp.2075~2083 (2009)
294. Linz D, "Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation", Heart Rhythm, 8, pp.1436~1443 (2011)
295. Linz D, "Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea", Hypertension, 60, pp.172~178 (2012)
296. Linz D, "Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea", Hypertension, 62, pp.767~774 (2013)
297. Iwasaki YK, "Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea", Heart Rhythm, 9, pp.1409~1416 e1 (2012)
298. Iwasaki YK, "Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model", J Am Coll Cardiol, 64, pp.2013~2023 (2014)
299. Dimitri H, "Atrial remodeling in obstructive sleep apnea : implications for atrial fibrillation", Heart Rhythm, 9, pp.321~327 (2012)
300. Stevenson IH, "Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia : implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea", Heart Rhythm, 7, pp.1263~1270 (2010)
301. Holmqvist F, "Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF)", Am Heart J, 169, pp.647~654 e2 (2015)
302. Kwon Y, "Association of sleep characteristics with atrial fibrillation : the Multi-Ethnic Study of Atherosclerosis", Thorax, 70, pp.873~879 (2015)
303. Kanagala R, "Obstructive sleep apnea and the recurrence of atrial fibrillation", Circulation, 107, pp.2589~2594 (2003)
304. Fein AS, "Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation", J Am Coll Cardiol, 62, pp.300~305 (2013)
305. Matiello M, "Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients", Europace, 12, pp.1084~1089 (2010)
306. Naruse Y, "Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation : clinical impact of continuous positive airway pressure therapy", Heart Rhythm, 10, pp.331~337 (2013)
307. Neilan TG, "Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation", J Am Heart Assoc, 2, pp.e000421~ (2013)
308. Li L, "Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment : a meta-analysis of observational studies", Europace, 16, pp.1309~1314 (2014)
309. Benjamin EJ, "Independent risk factors for atrial fibrillation in a population-based cohort", JAMA, 271, pp.840~844 (1994)
310. Kannel WB, "Epidemiologic features of chronic atrial fibrillation : the Framingham study", N Engl J Med, 306, pp.1018~1022 (1982)
311. Krahn AD, "The natural history of atrial fibrillation : incidence, risk factors, and prognosis in the Manitoba Follow-Up Study", Am J Med, 98, pp.476~484 (1995)
312. Thomas MC, "Blood pressure control and risk of incident atrial fibrillation", Am J Hypertens, 21, pp.1111~1116 (2008)
313. Tremblay-Gravel M, "Blood Pressure and Atrial Fibrillation : A Combined AF-CHF and AFFIRM Analysis", J Cardiovasc Electrophysiol, 26, pp.509~514 (2015)
314. Grundvold I, "Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men : a 35-year follow-up study", Hypertension, 59, pp.198~204 (2012)
315. Conen D, "Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women", Circulation, 119, pp.2146~2152 (2009)
316. Kistler PM, "Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure : implications for development of atrial fibrillation", Eur Heart J, 27, pp.3045~3056 (2006)
317. Berruezo A, "Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation", Eur Heart J, 28, pp.836~841 (2007)
318. Arya A, "Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients", Europace, 12, pp.173~180 (2010)
319. Santoro F, "Impact of Uncontrolled Hypertension on Atrial Fibrillation Ablation Outcome", JACC Clin Electrophysiol, 1, pp.164~173 (2015)
320. Pokushalov E, "A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension", J Am Coll Cardiol, 60, pp.1163~1170 (2012)
321. Pokushalov E, "Renal denervation for improving outcomes of catheter ablation in patients with atrial fibrillation and hypertension : early experience", Heart Rhythm, 11, pp.1131~1138 (2014)
322. Healey JS, "Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers : a meta-analysis", J Am Coll Cardiol, 45, pp.1832~1839 (2005)
323. Al Chekakie MO, "The effects of statins and reninangiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation", J Cardiovasc Electrophysiol, 18, pp.942~946 (2007)
324. Tayebjee MH, "Impact of angiotensin-converting enzymeinhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation", Europace, 12, pp.1537~1542 (2010)
325. Kato T, "What are arrhythmogenic substrates in diabetic rat atria", J Cardiovasc Electrophysiol, 17, pp.890~894 (2006)
326. Huxley RR, "Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation", Am J Cardiol, 108, pp.56~62 (2011)
327. Huxley RR, "Type 2 diabetes, glucose homeostasis and incident atrial fibrillation : the Atherosclerosis Risk in Communities study", Heart, 98, pp.133~138 (2012)
328. Lin KJ, "Impact of metabolic syndrome on the risk of atrial fibrillation recurrence after catheter ablation : systematic review and metaanalysis", J Interv Card Electrophysiol, 39, pp.211~223 (2014)
329. Ettinger PO, "Arrhythmias and the"Holiday Heart" : alcoholassociated cardiac rhythm disorders", Am Heart J, 95, pp.555~562 (1978)
330. Qiao Y, "Impact of Alcohol Consumption on Substrate Remodeling and Ablation Outcome of Paroxysmal Atrial Fibrillation", J Am Heart Assoc, 4 (2015)
331. Wilber DJ, "Fibroblasts, focal triggers, and persistent atrial fibrillation: is there a connection", Circ Arrhythm Electrophysiol, 5, pp.249~251 (2012)
332. Qureshi WT, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation : Results From the Henry Ford Exercise Testing(FIT)Project", Circulation, 131, pp.1827~1834 (2015)
333. Malmo V, "Aerobic Interval Training Reduces the Burden of Atrial Fibrillation in the Short Term : A Randomized Trial", Circulation, 133, pp.466~473 (2016)
334. Abdulla J, "Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis", Europace, 11, pp.1156~1159 (2009)
335. Aizer A, "Relation of vigorous exercise to risk of atrial fibrillation", Am J Cardiol, 103, pp.1572~1577 (2009)
336. Mont L, "Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter", Europace, 11, pp.11~17 (2009)
337. Hoogsteen J, "Paroxysmal atrial fibrillation in male endurance athletes. A 9-year follow up", Europace, 6, pp.222~228 (2004)
338. Pelliccia A, "Prevalence and clinical significance of left atrial remodeling in competitive athletes", J Am Coll Cardiol, 46, pp.690~696 (2005)
339. Swanson DR, "Atrial fibrillation in athletes : implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism", Med Hypotheses, 66, pp.1085~1092 (2006)
340. Andersen K, "Risk of arrhythmias in 52 755 longdistance cross-country skiers : a cohort study", Eur Heart J, 34, pp.3624~3631 (2013)
341. Bettoni M, "Autonomic tone variations before the onset of paroxysmal atrial fibrillation", Circulation, 105, pp.2753~2759 (2002)
342. Pelliccia A, "Physiologic left ventricular cavity dilatation in elite athletes", Ann Intern Med, 130, pp.23~31 (1999)
343. Eijsvogels TM, "Are There Deleterious Cardiac Effects of Acute and Chronic Endurance Exercise", Physiol Rev, 96, pp.99~125 (2016)
344. Allison MA, "Sedentary behavior and adiposity-associated inflammation : the Multi-Ethnic Study of Atherosclerosis", Am J Prev Med, 42, pp.8~13 (2012)
345. Kasapis C, "The effects of physical activity on serum C-reactive protein and inflammatory markers : a systematic review", J Am Coll Cardiol, 45, pp.1563~1569 (2005)
346. Engelmann MD, "Inflammation in the genesis and perpetuation of atrial fibrillation", Eur Heart J, 26, pp.2083~2092 (2005)
347. Chung MK, "C-reactive protein elevation in patients with atrial arrhythmias : inflammatory mechanisms and persistence of atrial fibrillation", Circulation, 104, pp.2886~2891 (2001)
348. Korantzopoulos P, "Atrial fibrillation and electrical remodeling: the potential role of inflammation and oxidative stress", Med Sci Monit, 9, pp.RA225~RA229 (2003)
349. Psychari SN, "Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation", Am J Cardiol, 95, pp.764~767 (2005)
350. Mohlenkamp S, "Running : the risk of coronary events : Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners", Eur Heart J, 29, pp.1903~1910 (2008)
351. Marrouche NF, "Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation : the DECAAF study", JAMA, 311, pp.498~506 (2014)
352. Benito B, "Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training", Circulation, 123, pp.13~22 (2011)
353. Lindsay MM, "Biochemical evidence of myocardial fibrosis in veteran endurance athletes", Br J Sports Med, 41, pp.447~452 (2007)
354. Gay-Jordi G, "Losartan prevents heart fibrosis induced by long-term intensive exercise in an animal model", PLoS One, 8, pp.e55427~ (2013)
355. Sorokin AV, "Atrial fibrillation in endurance-trained athletes", Br J Sports Med, 45, pp.185~188 (2011)
356. Calvo N, "Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes", Europace, 12, pp.30~36 (2010)
357. Koopman P, "Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation", Europace, 13, pp.1386~1393 (2011)
358. Furlanello F, "Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition", J Cardiovasc Electrophysiol, 19, pp.457~462 (2008)
359. Fjeldsoe B, "Systematic review of maintenance of behavior change following physical activity and dietary interventions", Health Psychol, 30, pp.99~109 (2011)
360. Pappone C, "A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation", J Am Coll Cardiol, 48, pp.2340~2347 (2006)
361. Stabile G, "Catheter ablation treatment in patients with drug-refractory atrial fibrillation : a prospective, multi-centre, randomized, controlled study(Catheter Ablation For The Cure Of Atrial Fibrillation Study)", Eur Heart J, 27, pp.216~221 (2006)
362. Jaïs P, "Catheter Ablation Versus Antiarrhythmic Drugs for Atrial FibrillationCLINICAL PERSPECTIVE : The A4 Study", Circulation, 118, pp.2498~2505 (2008)
363. Calkins H, "Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency AblationCLINICAL PERSPECTIVE : Two Systematic Literature Reviews and Meta-Analyses", Circ Arrhythm Electrophysiol, 2, pp.349~361 (2009)
364. Wilber DJ, "Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation : A Randomized Controlled Trial", JAMA, 303, pp.333~340 (2010)
365. Packer DL, "Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial FibrillationFirst Results of the North American Arctic Front(STOP AF)Pivotal Trial", J Am Coll Cardiol, 61, pp.1713~1723 (2013)
366. Natale A, "Paroxysmal AF Catheter Ablation With a Contact Force Sensing Catheter", J Am Coll Cardiol, 64, pp.647~656 (2014)
367. Reddy VY, "Randomized, Controlled Trial of the Safety and Effectiveness of a Contact Force–Sensing Irrigated Catheter for Ablation of Paroxysmal Atrial Fibrillation Results of the TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation(TOCCASTAR)Study", Circulation, 132, pp.907~915 (2015)
368. Kuck KH, "Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation", N Engl J Med, 374, pp.2235~2245 (2016)
369. Verma A, "Approaches to Catheter Ablation for Persistent Atrial Fibrillation", N Engl J Med, 372, pp.1812~1822 (2015)
370. Scherr D, "Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint", Circ Arrhythm Electrophysiol, 8, pp.18~24 (2015)
371. Hummel J, "Phased RF ablation in persistent atrial fibrillation", Heart Rhythm, 11, pp.202~209 (2014)
372. Bassiouny M, "Randomized Study of Persistent Atrial Fibrillation Ablation: Ablate in Sinus Rhythm Versus Ablate Complex-Fractionated Atrial Electrograms in Atrial Fibrillation", Circ Arrhythm Electrophysiol, 9, pp.e003596~ (2016)
373. "Circumferential Pulmonary-Vein Ablation for Chronic Atrial Fibrillation", N Engl J Med, 8 (2006)
374. Mont L, "Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study)", Eur Heart J, pp.eht457~ (2013)
375. Kim J-S, "Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation?", Int J Cardiol, 181, pp.277~283 (2015)
376. Yu HT, "Pulmonary Vein Isolation Alone Versus Additional Linear Ablation in Patients With Persistent Atrial Fibrillation Converted to Paroxysmal Type With Antiarrhythmic Drug Therapy: A Multicenter, Prospective, Randomized Study", Circ Arrhythm Electrophysiol, 10, pp.e004915~ (2017)
377. Wazni OM, "Radiofrequency Ablation vs Antiarrhythmic Drugs as First-line Treatment of Symptomatic Atrial Fibrillation : A Randomized Trial", JAMA, 293, pp.2634~2640 (2005)
378. Cosedis Nielsen J, "Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation", N Engl J Med, 367, pp.1587~1595 (2012)
379. Morillo CA, "Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation(RAAFT-2) : A Randomized Trial", JAMA, 311, pp.692~700 (2014)
380. Hakalahti A, "Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis", EP Eur, 17, pp.370~378 (2015)
381. Hocini M, "Reverse Remodeling of Sinus Node Function After Catheter Ablation of Atrial Fibrillation in Patients With Prolonged Sinus Pauses", Circulation, 108, pp.1172~1175 (2003)
382. Chen YW, "Pacing or Ablation: Which Is Better for Paroxysmal Atrial Fibrillation‐Related Tachycardia‐Bradycardia Syndrome", Pacing Clin Electrophysiol, 37, pp.403~411 (2014)
383. Inada K, "The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses : outcome during a 5-year follow-up", Europace, 16, pp.208~213 (2014)
384. Chen MS, "Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function", J Am Coll Cardiol, 43, pp.1004~1009 (2004)
385. Gentlesk PJ, "Reversal of Left Ventricular Dysfunction Following Ablation of Atrial Fibrillation", J Cardiovasc Electrophysiol, 18, pp.9~14 (2006)
386. Khan MN, "Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure", N Engl J Med, 359, pp.1778~1785 (2008)
387. MacDonald MR, "Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction : a randomised controlled trial", Heart, 97, pp.740~747 (2011)
388. Hunter RJ, "A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure(The CAMTAF Trial)", Circ Arrhythm Electrophysiol, 7, pp.31~38 (2014)
389. Lutomsky BA, "Catheter ablation of paroxysmal atrial fibrillation improves cardiac function : a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging", EP Eur, 10, pp.593~599 (2008)
390. Choi AD, "Ablation vs Medical Therapy in the Setting of Symptomatic Atrial Fibrillation and Left Ventricular Dysfunction", Congest Heart Fail, 16, pp.10~14 (2010)
391. Jones DG, "A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart Failure", J Am Coll Cardiol, 61, pp.1894~1903 (2013)
392. Machino-Ohtsuka T, "Efficacy, Safety, and Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction", J Am Coll Cardiol, 62, pp.1857~1865 (2013)
393. Halabi SA, "Catheter Ablation for Atrial Fibrillation in Heart Failure Patients : A Meta-Analysis of Randomized Controlled Trials", JACC Clin Electrophysiol, 1, pp.200~ (2015)
394. Bunch TJ, "Five‐Year Outcomes of Catheter Ablation in Patients with Atrial Fibrillation and Left Ventricular Systolic Dysfunction", J Cardiovasc Electrophysiol, 26, pp.363~370 (2015)
395. Ling LH, "Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation", Heart Rhythm, 10, pp.1334~1339 (2013)
396. Li-Fern H, "Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure", N Engl J Med, 11 (2004)
397. Marrouche NF, "Catheter Ablation for Atrial Fibrillation with Heart Failure", N Engl J Med, 378, pp.417~427 (2018)
398. Kusumoto F, "Radiofrequency catheter ablation of atrial fibrillation in older patients : outcomes and complications", J Interv Card Electrophysiol, 25, pp.31~35 (2009)
399. Bunch TJ, "Long‐Term Clinical Efficacy and Risk of Catheter Ablation for Atrial Fibrillation in Octogenarians", Pacing Clin Electrophysiol, 33, pp.146~152 (2009)
400. Santangeli P, "Catheter Ablation of Atrial Fibrillation in Octogenarians : Safety and Outcomes", J Cardiovasc Electrophysiol, 23, pp.687~693 (2012)
401. Nademanee K, "Benefits and risks of catheter ablation in elderly patients with atrial fibrillation", Heart Rhythm, 12, pp.44~51 (2015)
402. Bunch TJ, "The Impact of Age on 5‐Year Outcomes After Atrial Fibrillation Catheter Ablation", J Cardiovasc Electrophysiol, 27, pp.141~146 (2016)
403. Metzner I, "Ablation of atrial fibrillation in patients ≥75 years : long-term clinical outcome and safety", EP Eur, 18, pp.543~549 (2016)
404. Bunch TJ, "Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy", J Cardiovasc Electrophysiol, 19, pp.1009~1014 (2008)
405. Olivotto I, "Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy", Circulation, 104, pp.2517~2524 (2001)
406. Providencia R, "Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy : a systematic review and metaanalysis", Heart, 102, pp.1533~1543 (2016)
407. Roh S-Y, "Long-Term Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Apical Hypertrophic Cardiomyopathy", J Cardiovasc Electrophysiol, 27, pp.788~795 (2016)
408. Leong-Sit P, "Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of AgeClinical Perspective", Circ Arrhythm Electrophysiol, 3, pp.452~457 (2010)
409. Chun KRJ, "Catheter ablation of atrial fibrillation in the young : insights from the German Ablation Registry", Clin Res Cardiol, 102, pp.459~468 (2013)
410. Calvo N, "Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes", EP Eur, 12, pp.30~36 (2010)
411. Koopman P, "Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation", EP Eur, 13, pp.1386~1393 (2011)
412. Forleo GB, "Clinical impact of catheter ablation in patients with asymptomatic atrial fibrillation : The IRON-AF(Italian Registry on NavX Atrial Fibrillation Ablation Procedures)study", Int J Cardiol, 168, pp.3968~3970 (2013)
413. Wu L, "Comparison of Radiofrequency Catheter Ablation Between Asymptomatic and Symptomatic Persistent Atrial Fibrillation : A Propensity Score Matched Analysis", J Cardiovasc Electrophysiol, 27, pp.531~535 (2016)
414. Mohanty S, "Catheter Ablation of Asymptomatic Longstanding Persistent Atrial Fibrillation : Impact on Quality of Life, Exercise Performance, Arrhythmia Perception, and Arrhythmia‐Free Survival", J Cardiovasc Electrophysiol, 25, pp.1057~1064 (2014)
415. Badhwar V, "The Society of Thoracic Surgeons Mitral Repair", Replacement Composite Score : A Report of The Society of Thoracic Surgeons Quality Measurement Task Force, 2016, pp.101, 2265~2271
416. Filho CACA, "Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease", Circulation, 112, pp.I-20~I-25 (2005)
417. Doukas G, "Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation : A Randomized Controlled Trial", JAMA, 294, pp.2323~2329 (2005)
418. Blomström-Lundqvist C, "A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery : the SWEDish Multicentre Atrial Fibrillation study(SWEDMAF)", Eur Heart J, 28, pp.2902~2908 (2007)
419. Chevalier P, "Left atrial radiofrequency ablation during mitral valve surgery : a prospective randomized multicentre study(SAFIR)", Arch Cardiovasc Dis, 102, pp.769~775 (2009)
420. Budera P, "Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and", or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study, 2012, pp.33, 2644~2652
421. Phan K, "Surgical ablation for treatment of atrial fibrillation in cardiac surgery : a cumulative meta-analysis of randomised controlled trials", Heart, 100, pp.722~730 (2014)
422. Gillinov AM, "Surgical Ablation of Atrial Fibrillation during Mitral-Valve Surgery", N Engl J Med, 372, pp.1399~1409 (2015)
423. Rankin JS, "The Society of Thoracic Surgeons Risk Model for Operative Mortality After Multiple Valve Surgery", Ann Thorac Surg, 95, pp.1484~1490 (2013)
424. Louagie Y, "Improved Patient Survival With Concomitant Cox Maze III Procedure Compared With Heart Surgery Alone", Ann Thorac Surg, 87, pp.440~446 (2009)
425. Barnett SD, "Surgical ablation as treatment for the elimination of atrial fibrillation : A meta-analysis", J Thorac Cardiovasc Surg, 131, pp.1029~1035 (2006)
426. Kim HJ, "Surgical ablation of atrial fibrillation in patients with a giant left atrium undergoing mitral valve surgery", Heart, 102, pp.1206~1214 (2016)
427. Edgerton JR, "A New Epicardial Lesion Set for Minimal Access Left Atrial Maze : The Dallas Lesion Set", Ann Thorac Surg, 88, pp.1655~1657 (2009)
428. Edgerton JR, "Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the “Dallas” lesion set", Heart Rhythm, 6, pp.S64~S70 (2009)
429. Lockwood D, "Linear left atrial lesions in minimally invasive surgical ablation of persistent atrial fibrillation: Techniques for assessing conduction block across surgical lesions", Heart Rhythm, 6, pp.S50~S63 (2009)
430. Cherniavsky A, "Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders", Interact Cardiovasc Thorac Surg, 18, pp.727~731 (2014)
431. Yoo JS, "Impact of Concomitant Surgical Atrial Fibrillation Ablation in Patients Undergoing Aortic Valve Replacement", Circ J, 78, pp.1364~1371 (2014)
432. Driessen AHG, "Ganglion Plexus Ablation in Advanced Atrial Fibrillation", J Am Coll Cardiol, 68, pp.1155~1165 (2016)
433. Boersma LVA, "Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment(FAST)Clinical Perspective : A 2-Center Randomized Clinical Trial", Circulation, 125, pp.23~30 (2012)
434. Henn MC, "Late outcomes after the Cox maze IV procedure for atrial fibrillation", J Thorac Cardiovasc Surg, 150, pp.1168~1178.e2 (2015)
435. Krul SPJ, "Navigating the minimaze : Systematic review of the first results and progress of minimally-invasive surgery in the treatment of atrial fibrillation", Int J Cardiol, 166, pp.132~140 (2013)
436. Wolf RK, "Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation", J Thorac Cardiovasc Surg, 130, pp.797~802 (2005)
437. Edgerton JR, "Minimally Invasive Pulmonary Vein Isolation and Partial Autonomic Denervation for Surgical Treatment of Atrial Fibrillation", Ann Thorac Surg, 86, pp.35~39 (2008)
438. Edgerton JR, "Minimally invasive surgical ablation of atrial fibrillation : Sixmonth results", J Thorac Cardiovasc Surg, 138, pp.109~114 (2009)
439. Beyer E, "Point : Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation : Early multicenter results", J Thorac Cardiovasc Surg, 137, pp.521~526 (2009)
440. Kearney K, "A systematic review of surgical ablation versus catheter ablation for atrial fibrillation", Ann Cardiothorac Surg, 3, pp.15~29 (2014)
441. Ad N, "Surgical ablation of atrial fibrillation trends and outcomes in North America", J Thorac Cardiovasc Surg, 144, pp.1051~1060 (2012)
442. Driessen AHG, "Electrophysiologically Guided Thoracoscopic Surgery for Advanced Atrial Fibrillation", J Am Coll Cardiol, 69, pp.1753~1754 (2017)
443. Khargi K, "Surgical treatment of atrial fibrillation; a systematic review", Eur J Cardiothorac Surg, 27, pp.258~265 (2005)
444. Wazni OM, "Atrial Arrhythmias After Surgical Maze", J Am Coll Cardiol, 48, pp.1405~1409 (2006)
445. Magnano AR, "Mechanisms of Atrial Tachyarrhythmias Following Surgical Atrial Fibrillation Ablation", J Cardiovasc Electrophysiol, 17, pp.366~373 (2006)
446. McElderry HT, "Proarrhythmic Aspects of Atrial Fibrillation Surgery : Mechanisms of Postoperative Macroreentrant Tachycardias", Circulation, 117, pp.155~162 (2008)
447. McCarthy PM, "Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation", J Thorac Cardiovasc Surg, 139, pp.860~867 (2010)
448. Zeng Y, "Recurrent Atrial Arrhythmia After Minimally Invasive Pulmonary Vein Isolation for Atrial Fibrillation", Ann Thorac Surg, 90, pp.510~515 (2010)

관련 논문AI추천